Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2018 | Key factors in the tumor-tumor microenvironment relationship in myeloma

Bruno Paiva, PhD, from the University of Navarra, Navarra, Spain, shares insights into multiple myeloma (MM) from the 23rd congress of European Hematology Association (EHA) 2018, held in Stockholm, Sweden, including the pathogenesis of the disease,and the role of the tumor microenvironment. Dr Paiva also discusses the novel therapies that are being introduced for the management of MM, such as immunomodulatory drugs and monoclonal antibodies, and how these can be combined with existing treatments in the future.